Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Waste Management (New York, N.Y.)|February 23, 2021
Assessing the potential of sewage sludge-derived biochar as a novel phosphorus fertilizer: Influence of extractant solutions and pyrolysis temperaturesCícero Célio de Figueiredo, Arthur de Souza Prado Junqueira Reis, Alyson Silva de Araujo, et al.
Journal of Environmental Management|September 5, 2024
A critical review on emerging industrial applications of chars from thermal treatment of biosolidsMojtaba Hedayati Marzbali, Ibrahim Gbolahan Hakeem, Tien Ngo, et al.
Waste Management (New York, N.Y.)|February 10, 2023
Production of H<sub>2</sub> and CNM from biogas decomposition using biosolids-derived biochar and the application of the CNM-coated biochar for PFAS adsorptionSavankumar Patel, Mojtaba Hedayati Marzbali, Ibrahim Gbolahan Hakeem, et al.
The Science of the Total Environment|June 25, 2024
Can pyrolysis handle biomedical wastes?: Assessing the potential of various biomedical waste treatment technologies in tackling pandemicsAkshay Srivastava, Anita Sharma, Manoj Kumar Jena, et al.
The Science of the Total Environment|December 31, 2023
Waste to energy: Trending key challenges and current technologies in waste plastic managementSai Sree Varsha Vuppaladadiyam, Arun K Vuppaladadiyam, Abhisek Sahoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2025
Clinical Context Shapes the Relationship Between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate CancerKalpit Shah, Matthew H Secrest, Wei Zhou, et al.
Oncogene|March 16, 2018
LMTK3 confers chemo-resistance in breast cancerJustin Stebbing, Kalpit Shah, Lei Cheng Lit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
The Journal of Clinical Investigation|March 4, 2020
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progressionTeresa Gagliano, Kalpit Shah, Sofia Gargani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker ResultsPeter Schmid, Nicholas C Turner, Carlos H Barrios, et al.
Pageof 6